相关临床试验
0
0 进行中
药物批准
2
批准总数
监管机构
1
监管机构数
成立时间
N/A
暂无试验阶段数据
暂无试验数据
暂无试验数据
<p><strong>4.1 Therapeutic indications</strong></p> <p>IXIARO is indicated for active immunization against Japanese encephalitis in adults, adolescents, children and infants aged 2 months and older.</p> <p>IXIARO should be considered for use in individuals at risk of exposure through travel or in the course of their occupation.</p>
暂无资讯文章
